Skip to main content

Want a detailed portfolio tracker?

Scholar Rock (SRRK) P/E (2018 - 2026)

Scholar Rock (SRRK) P/E from Jul 2, 2018 to Jul 20, 2026. The TTM Scholar Rock (SRRK) P/E is -12.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Scholar Rock (SRRK)

YearP/EChange
2026-12.99+12.11%
2025-11.58-20.73%
2024-14.61+129.88%
2023-6.36+106.17%
2022-3.08-52.84%
2021-6.54-62.51%
2020-17.44+134.30%
2019-7.44-48.82%
2018-14.54N/A

Comparison Scholar Rock (SRRK) P/E with competitors

Scholar Rock (SRRK) P/E is -12.99.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.58%
FGENFibroGen Inc0.24-101.85%
CHRSCoherus Biosciences Inc0.85-106.53%
FBIOFortress Biotech Inc0.95-107.31%
ORMPOramed Pharmaceuticals Inc1.50-111.57%
AGENAgenus Inc3.01-123.18%
INVAInnoviva Inc3.15-124.29%
VXRTVaxart Inc3.55-127.34%
CRMDCorMedix Inc3.63-127.94%
CVACCureVac N.V.4.45-134.24%
GLPGGalapagos NV4.86-137.42%
ABEOAbeona Therapeutics Inc5.39-141.49%
ABUSArbutus Biopharma Corp5.60-143.09%
ZVRAZevra Therapeutics Inc5.89-145.34%
SPROSpero Therapeutics Inc6.23-147.96%
CGENCompugen Ltd6.31-148.62%
RIGLRigel Pharmaceuticals6.87-152.92%
SLXNSilexion Therapeutics Corp7.30-156.19%
OMEROmeros Corporation9.26-171.30%
AUPHAurinia Pharmaceuticals Inc9.58-173.81%
PLXProtalix BioTherapeutics Inc10.89-183.87%
ACADAcadia Pharmaceuticals Inc11.73-190.32%
TBPHTheravance Biopharma Inc12.26-194.43%
ADMAAdma Biologics Inc12.42-195.63%
HRMYHarmony Biosciences Holdings Inc13.82-206.43%
SABSSAB Biotherapeutics Inc14.14-208.86%
NAGENiagen Bioscience Inc14.82-214.11%
INCYIncyte Corp15.82-221.85%
REGNRegeneron Pharmaceuticals Inc15.86-222.11%
PBYIPuma Biotechnology Inc17.32-233.35%
CPRXCatalyst Pharmaceuticals Inc17.44-234.30%
EXELExelixis Inc17.54-235.06%
TGTXTG Therapeutics Inc18.97-246.06%
MDXGMimedx Group Inc20.55-258.27%
XOMAXOMA Royalty Corp22.87-276.16%
ARGXArgen X SE24.30-287.12%
CTMXCytomX Therapeutics Inc24.82-291.15%
XOMAOXOMA Royalty Corp25.34-295.18%
HALOHalozyme Therapeutics Inc25.62-297.33%
XOMAPXOMA Royalty Corp25.67-297.69%
VRTXVertex Pharmaceuticals Inc27.99-315.59%
RPRXRoyalty Pharma plc - Class A28.69-320.92%
SLNOSoleno Therapeutics Inc29.02-323.45%
ASNDAscendis Pharma A/S30.09-331.69%
LGNDLigand Pharmaceuticals Inc - Class B37.91-391.96%
APLSApellis Pharmaceuticals Inc39.02-400.51%
BMRNBiomarin Pharmaceutical Inc42.21-425.08%
KRYSKrystal Biotech Inc45.34-449.19%
ONCBeiGene Ltd69.54-635.54%
PHARPharming Group N.V.75.03-677.78%
TECHBio-Techne Corp101.96-885.19%
VCELVericel Corp109.92-946.51%
ALNYAlnylam Pharmaceuticals Inc117.96-1008.46%
GMABGenmab140.29-1180.39%
TLXTelix Pharmaceuticals Ltd162.15-1348.75%
CORTCorcept Therapeutics Inc212.86-1739.23%